药品注册申请号:040517
申请类型:ANDA (仿制药申请)
申请人:SPECGX LLC
申请人全名:SPECGX LLC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG No Yes AA 2004/04/27 2004/04/27 Prescription
002 METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG No Yes AA 2004/04/27 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/01/03 SUPPL-37(补充) Approval Labeling STANDARD
2024/01/03 SUPPL-36(补充) Approval Labeling STANDARD
2023/12/31 SUPPL-35(补充) Approval Labeling STANDARD
2022/03/16 SUPPL-28(补充) Approval Labeling STANDARD
2022/03/16 SUPPL-26(补充) Approval Labeling STANDARD
2022/03/16 SUPPL-24(补充) Approval Labeling STANDARD
2022/03/16 SUPPL-23(补充) Approval Labeling STANDARD
2021/06/02 SUPPL-30(补充) Approval Labeling STANDARD
2018/09/18 SUPPL-25(补充) Approval REMS
2017/05/26 SUPPL-22(补充) Approval REMS
2016/10/28 SUPPL-19(补充) Approval Labeling STANDARD
2016/09/30 SUPPL-20(补充) Approval REMS
2016/04/20 SUPPL-18(补充) Approval REMS
2015/06/26 SUPPL-15(补充) Approval REMS
2015/06/01 SUPPL-16(补充) Approval Labeling STANDARD
2014/08/19 SUPPL-14(补充) Approval REMS
2014/07/23 SUPPL-12(补充) Approval Labeling STANDARD
2013/04/15 SUPPL-9(补充) Approval REMS
2012/07/09 SUPPL-8(补充) Approval Labeling
2012/07/09 SUPPL-7(补充) Approval REMS
2008/01/26 SUPPL-4(补充) Approval Manufacturing (CMC)
2007/01/10 SUPPL-3(补充) Approval Labeling
2006/03/02 SUPPL-2(补充) Approval Labeling
2004/04/27 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:METHADONE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:5MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
088108 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG Prescription No No AA 1983/03/08 ROXANE
040517 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG Prescription No Yes AA 2004/04/27 SPECGX LLC
090065 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG Prescription No No AA 2015/08/18 EPIC PHARMA LLC
203502 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG Prescription No No AA 2015/08/31 AUROLIFE PHARMA LLC
208305 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG Discontinued No No AA 2018/03/30 SUN PHARM INDUSTRIES
211228 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG Prescription No No AA 2019/01/03 ASCENT PHARMS INC
090635 002 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 5MG Prescription No No AA 2020/09/22 THEPHARMANETWORK LLC
活性成分:METHADONE HYDROCHLORIDE 剂型/给药途径:TABLET;ORAL 规格:10MG 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
088109 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No No AA 1983/03/08 ROXANE
040241 002 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No No AA 1998/05/29 VISTAPHARM LLC
040517 002 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No Yes AA 2004/04/27 SPECGX LLC
090635 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No No AA 2009/11/25 THEPHARMANETWORK LLC
090065 002 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No No AA 2015/08/18 EPIC PHARMA LLC
203502 002 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No No AA 2015/08/31 AUROLIFE PHARMA LLC
208305 002 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Discontinued No No AA 2018/03/30 SUN PHARM INDUSTRIES
211228 002 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No No AA 2019/01/03 ASCENT PHARMS INC
204166 001 ANDA METHADONE HYDROCHLORIDE METHADONE HYDROCHLORIDE TABLET;ORAL 10MG Prescription No No AA 2020/03/16 VISTAPHARM LLC
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database